Exit
Carbon accounting software company Normative, a Horizons Ventures portfolio company, was acquired by Greenly in a deal valued at ~€64M to build a top global climate software provider.
Normative
SEP 11, 2026
Exit
Kelonia Therapeutics, a gene therapy developer focused on cancer in which Horizons Ventures was a Series A investor, was acquired by Eli Lilly for up to $7 billion ($3.25B upfront + $3.75B in milestones).
Kelonia
APR 20, 2026